- Exchange: NASDAQ CM
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Cell Therapeutics Inc
+ Add to WatchlistCTIC:US
1.2400 USD 0.0200 1.64%As of 20:10:00 ET on 05/24/2013.
Snapshot for Cell Therapeutics Inc (CTIC)
| Open: | 1.2100 | Day's Range: | 1.1900 - 1.2400 | Volume: | 673,918 |
|---|---|---|---|---|---|
| Previous Close: | 1.2400 | 52wk Range: | 1.0200 - 4.7150 | 1-Yr Rtn: | -73.04% |
Key Statistics for CTIC
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (USD) (ttm) | -1.4400 |
| Est. EPS (USD) (12/2013) | -0.6050 |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 139.67 |
| Shares Outstanding (M) | 112.63 |
| 30 Day Average Volume | 778,889 |
| Price/Book (mrq) | 4.4480 |
| Price/Sale (ttm) | 117.4994 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/01/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for CTIC
Company Profile & Key Executives for CTIC
Cell Therapeutics, Inc. is a biopharmaceutical company. The Company researches and develops cancer drugs.
| James A BiancoPresident/CEO/Co-Founder | Louis A BiancoExec VP:Finance/Co-Founder |
| Jack W SingerExec VP:Global Medical Affairs | Steven E BennerExec VP/Chief Medical Officer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
CTIC News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page